AD, P., N, G., K, J., Q, C., ER, L., C, C., . . . G, V. (2022). Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. European journal of cancer (Oxford, England : 1990), 173, 71. https://doi.org/10.1016/j.ejca.2022.06.008
Chicago Style (17th ed.) CitationAD, Pearson, et al. "Paediatric Strategy Forum for Medicinal Product Development of Multi-targeted Kinase Inhibitors in Bone Sarcomas: ACCELERATE in Collaboration with the European Medicines Agency with Participation of the Food and Drug Administration." European Journal of Cancer (Oxford, England : 1990) 173 (2022): 71. https://doi.org/10.1016/j.ejca.2022.06.008.
MLA (9th ed.) CitationAD, Pearson, et al. "Paediatric Strategy Forum for Medicinal Product Development of Multi-targeted Kinase Inhibitors in Bone Sarcomas: ACCELERATE in Collaboration with the European Medicines Agency with Participation of the Food and Drug Administration." European Journal of Cancer (Oxford, England : 1990), vol. 173, 2022, p. 71, https://doi.org/10.1016/j.ejca.2022.06.008.
